Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Dova Pharmaceuticals, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $86.3 million initial public offering of common…
Mersana Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000…
Royal Philips Acquires Spectranetics
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to The Spectranetics Corporation in connection with…
Teladoc, Inc. $275 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchaser in connection with a Rule 144A offering by Teladoc, Inc. of $275 million aggregate…
Bristol-Myers Squibb Company Debt Tender Offer
Davis Polk advised the dealer manager on a cash tender offer by Bristol-Myers Squibb Company for any and all of its 5.875%…
Loxo Oncology, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $260.8 million SEC-registered offering of 3,622,500…
Cardinal Health $5.2 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Cardinal Health, Inc…
NanoString Technology Public Stock Offering
Davis Polk advised the sole underwriter in connection with the public offering of 3,450,000 shares of common stock of…
Achaogen Common Stock Offering
Davis Polk advised the joint book-running managers in connection with the $112.5 million public offering of common…